市场监管总局批准建立首套β辐射组织吸收剂量国家基准装置

Group 1 - The State Administration for Market Regulation has approved the establishment of China's first national standard device for β radiation tissue absorption dose, developed by the China Institute of Metrology Science, aimed at improving measurement standard accuracy in fields such as radiological medicine and nuclear safety [1] - China Dongfang (01763.HK), as a company related to nuclear medicine, may benefit indirectly from the industry's technological upgrades, but attention should be paid to the actual impact of subsequent policy implementation on its business [1] Group 2 - In the recent trading period from February 5 to February 11, 2026, China Dongfang's stock price increased by 1.48%, but exhibited significant volatility, with a drop of 2.23% on February 5 and a further decline of 1.42% on February 6, followed by rebounds of 3.18% and 2.33% on February 9 and 10, respectively, and a slight decrease of 0.27% to HKD 21.88 on February 11 [2] - Technical indicators show that the MACD histogram turned negative on February 11 (-0.113), while the KDJ indicator rose from the oversold region to 54.19, indicating short-term fluctuations; additionally, there has been a continuous net outflow of funds, with a net outflow of HKD 848,900 on February 11, reflecting some profit-taking by investors [2]